AI research center opens at Canadian medical school

Dave Pearson | | Health Exec | Precision Medicine
Toronto

North of the border, two grants of $200,000 are on offer for researchers innovating transformative ways to apply AI in healthcare—and they’re only one part of an ambitious academic endeavor to expand medical AI.

The University of Toronto announced the undertaking Dec. 9. The work as a whole is the launch of the school’s new Temerty Centre for AI Research and Education in Medicine, or T-CAIREM.

The school says the center hit the ground running, as around 400 researchers pre-joined this past summer.

“Toronto is uniquely positioned to lead globally in artificial intelligence in healthcare,” says Muhammad Mamdani, PharmD, MPH, the center’s inaugural director. “Our expertise in medicine and allied health sciences, computer science, statistics, mathematics and engineering is among the best in the world.”

Full announcement here.

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

Cardiovascular Business
AMA House of Delegates helps cardiology groups influence healthcare policies

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

Cardiovascular Business
Smaller revenues, less growth: In US, tariffs may create headaches for $34.5B cardiovascular device market

“Without a more concrete and stable policy on these tariffs from the current American administration, it is likely that most manufacturers will be forced to continuously change their internal forecasts and production plans," one analyst said.